Navigation Links
Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
Date:5/14/2009

al. "Clinical Course of Patients with Non -Small Cell Lung Cancer and Epidermal Growth Factor Receptor Exon19 and Exon 21 Mutations Treated with Gefitinib or Erlotinib." Clin. Cancer Res, 12, 839-844(2006). Available at: http://clincancerres.aacrjournals.org/cgi/reprint/12/3/839. Accessed on 5 May 2009.
  • Balak, M. N. et al. "Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors." Clin. Cancer Res. 12, 6494-6500 (2006). Available at: http://clincancerres.aacrjournals.org/cgi/reprint/12/21/6494. Accessed on 5 May 2009.
  • Ledermann, J. A. "A randomised Phase II placebo-controlled trial using maintenance therapy to evaluate the vascular targeting agent BIBF 1120 followign treatment of relapsed ovarian cancer (OC)." Oral presentation, Clinical Science Symposium. Monday, 1 June 2009, Session Time 9:45AM - 11:15AM. # 5501
  • Hilberg F. et al. "BIBF1120 a novel, small molecule triple angiokinase inhibitor: profiling as a clinical candidate for cancer therapy." European Journal of Cancer Supplements. 2004; 2:50.
  • Lewis J. Kleinsmith. "Understanding Cancer and Related Topics: Understanding Angiogenesis." Rockville: National Cancer Institute, 2006. Available at: http://cancer.gov/cancertopics/understandingcancer. Accessed on 5 May 2009.
  • P Bo
    '/>"/>

    • SOURCE Boehringer Ingelheim
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Boehringer Ingelheim Initiates NEwArT Study Comparing Viramune(R) (nevirapine) to a Ritonavir-Boosted Atazanavir-based Regimen in Treatment-Naive HIV Patients
    2. Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study
    3. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
    4. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
    5. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
    8. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
    9. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
    10. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
    11. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/15/2009)... LAWRENCE, Mass., Dec. 15 OBP Medical ... comfort and overall patient satisfaction in hospitals. ,, ... measuring the positive effects of OBP Medical,s Under ... hospital stay. A hospital wide survey is comparing ... of their stay while wearing Under Johnnies(TM) against ...
    (Date:12/14/2009)... sometimes uncomfortable colonoscopies may soon be a thing of ... a new screening test that is making its way ... EDP Biotech Corporation (EDP) is pursuing a patent ... can use to screen for colon cancer with only ... of colon cancer deaths are avoidable by early screening, ...
    (Date:12/14/2009)... board of directors of Eli Lilly and Company (NYSE: ... the first quarter of 2010 of $0.49 a share ... is payable March 10, 2010 to shareholders of record ... 12, 2010. ,, Lilly, a leading innovation-driven corporation, is ... the latest research from its own worldwide laboratories and ...
    Breaking Medicine Technology:Under Johnnies(TM) Proven To Increase Patient Satisfaction by OBP Medical Inc. 2EDP Biotech Takes Next Step in the Development of ColoMarker 2EDP Biotech Takes Next Step in the Development of ColoMarker 3PROTOMED SA Chooses HyperWorks to Simulate Implantable Medical Devices 13279 1PROTOMED SA Chooses HyperWorks to Simulate Implantable Medical Devices 13279 2PROTOMED SA Chooses HyperWorks to Simulate Implantable Medical Devices 13279 3President Obama Presented With Startling Book The Art of Conscious Parenting by the American Foundation for Conscious Parenting 53200 1President Obama Presented With Startling Book The Art of Conscious Parenting by the American Foundation for Conscious Parenting 53200 2STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 1STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 2STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 3STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 4STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 5STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 6STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 7STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 8STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 9STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 10STERIS Corporation Announces Fiscal 2010 First Quarter Results 53198 11
    ... ISIS 301012 produced at least 45% additional,reduction ... therapies, CARLSBAD, Calif., May 17, 2007 /PRNewswire-FirstCall/ ... its ongoing,Phase 2 clinical trial of ISIS ... initial results of which were,presented in March ...
    ... Is Greater Than for Asthma,Rheumatoid Arthritis and Migraines, ... three out of,four ulcerative colitis (UC) sufferers (73 ... feeling well has become a normal part,of life. ... comes,to their relationship with a spouse (64 percent), ...
    Other Medicine Technology:Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 2Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 3Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 4Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS,301012 in Familial Hypercholesterolemia Patients 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 2Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 3Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 4Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 5Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 6Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 7Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 8Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many,Aspects of Daily Life 9
    (Date:12/15/2009)... ANGELES, Dec. 15 Comcast Corporation and Stand ... the first-ever video-on-demand (VOD) initiative Stand Up 2 ... critical funds for innovative cancer research. Debuting exclusively ... Cancer On Demand will feature an extraordinary library ... many of the world,s biggest stars and groups. ...
    (Date:12/15/2009)... HONG KONG, Dec. 15 /PRNewswire-Asia/ --, Key points:, ... Cells (South) Company, Limited with ... exclusive access to about 1 million new births, ... -- CordLife,s geographical footprint in Asia Pacific is enlarged, with, ... India, two of the largest and fastest, ...
    (Date:12/15/2009)... how will they get paid for patient care? Capture,s medical ... , ... Washington, DC (Vocus) December 15, ... codes. These codes are what healthcare providers submit to ... medical consultation, whether in a provider’s office or hospital setting. ...
    (Date:12/15/2009)... want to earn your trust as the most caring, conscientious practice ... Dr. Foshee into the Dermatology Center of Dallas, we can help ... ... Dallas, TX (PRWEB) December 15, 2009 -- The Dermatology Center ... proudly announces the arrival of Jeri Beth “J.B.” Foshee, MD in ...
    (Date:12/15/2009)... that certain businesses with large areas where people gather, need ... Fire and rescue personnel agree that for any size business, ... , ... Issaquah, WA (PRWEB) December 15, ... certain businesses with large areas where people gather, need to ...
    Breaking Medicine News(10 mins):Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 2Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 3Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 5Health News:CordLife Secures Strategic Presence in China 2Health News:CordLife Secures Strategic Presence in China 3Health News:Medicare Eliminates Consultation Codes for Doctors 2Health News:Jeri Beth “J.B.” Foshee, MD Joins Dermatology Center of Dallas 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 2Health News:QuickMedical Responds to Oregon Bill Requiring Businesses to Carry Defibrillators 3
    ... fight social stigma, HIV carriers in Jharkhand have formed an ... with HIV has 200 members. More are likely to join. ... a humane manner. It will also seek assistance from the ... the infected. ,'Driving out HIV infected people ...
    ... State University says that the consumption of salad and ... C and E, lycopene and// alpha and beta carotene ... more than 17,500 men and women and have published ... Journal of the American Dietetic Association. The study also ...
    ... a risk of death almost three times pronounced for ... vaginal one.// , ,Catherine Deneux-Tharaux, M.D., M.P.H., ... had died either during or within a month after ... rather than a vaginal delivery; irrespective of whether the ...
    ... Australians live longer but with more disabilities among the aged. While ... in 1988, more people are suffering disabilities later in life, according ... ,Life expectancy for non-Indigenous Australian men has increased by ... 2003 can expect to live up to 77 and women up ...
    ... help overcome flood trauma? Yes, say psychiatrists here who have ... from the trauma caused by weeks of flooding.// ,A ... their daily routines and hum a motivational song when they ... on FM radio stations, the psychiatrists have convinced mobile telephone ...
    ... success of the first trial of the bird-flu vaccine on ... for which it requires 400 volunteers.// The second stage of ... afforded by the vaccine in the human body against the ... three phases of trial before being considered safe for administration. ...
    Other Medicine News:Health News:Salad Contains Nutrients In Optimum Level 2Health News:Songs Could Help to Overcome Flood Trauma 2
    ... Alerting System, instantly help protect individuals ... medical equipment), with easily-mountable exit controllers ... form of exit protection, you're quickly ... and overall peace of mind you're ...
    ... ProtecPoint Exit Alerting System, instantly ... staff) and assets (e.g. medical ... placed throughout your facility. With ... you're quickly ensured the cost ...
    ... VerdaSee Intelli-Storeroom™ was developed to create physically ... entrances and exits are converted to RFID ... RFID readers and antennas by VerdaSee's Field ... affixed to assets that are to be ...
    Radianse indoor positioning supports healthcare asset management with a way to locate medical equipment, devices and other portable assets....
    Medicine Products: